ANTRIMA Aventis Pharma
Drug Category: Folic acid inhibitor/sulphonamide.
Contents: DS Tabs: Trimethoprim 160mg, sulphadiazine 800mg.Susp: Per 5ml: Trimethoprim 40mg, sulphadiazine 200mg.Tabs: Trimethoprim 80mg, sulphadiazine 400mg.
Indications: Infections caused by grampositive and gram-negative organisms.
Dosage: DS Tabs: Adults: 1 tab twice daily.Susp: Adults: 20ml twice daily. Children: 6 months-5 years, 5ml; 5-12 years, 10ml. Both twice daily.
Tabs: 2 tabs twice daily.
Contra-ind. Precautions etc: See notes at the begining of this section.
Regn.No:Pack:Trade Prices:Retail Prices:
DS Tabs(010167):10x10's: 218.96:257.60.
Susp(009298):50ml: 13.78:16.21.
Tabs(009226) :20x10's: 218.96:257.60
Here You can search All About Health,Pharma,Medicine,A Thounds Articles and Medicine Pharma-Guide: Provides diverse and comprehensive data & information which can be helpful to the Pharmaceutical profession. Pharma-Guide: Provides the Country/Category wise Directory, the trade center, Bulk Drug Prices, details various exhibitions conducted from time to time worldwide. Pharma-Guide: Is a leader, promoting the industries in the global market.
Tuesday, January 8, 2008
Subscribe to:
Post Comments (Atom)
Infomed Drug Guide
The information contained in the "Infomed Drug Guide" is aimed at medical professionals and students of medicine and pharmacology. All of the data has been carefully compiled and checked, however, errors may occur. These errors may also result due to changes that have taken place in the medical sciences since the publication of the Drug Guide in 1994/2008, and cannot be excluded. In case of doubt, readers are encouraged to confirm the information contained herein with other sources before a drug is prescribed. Non-professionals should be aware that the "Infomed Drug Guide" does not seek to replace professional medical advice and/or treatment. Neither Infomed, nor the authors, claim that the information is in every respect accurate or complete. As a result, neither can be held responsible for any errors or omissions, or for any consequences resulting from the use of such information.
No comments:
Post a Comment